Related Experiment Video
Updated: May 18, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Interactions between CYP2E1 and CYP2B4: effects on affinity for NADPH-cytochrome P450 reductase and substrate
Cesar Kenaan1, Erin V Shea, Hsia-lien Lin
1Chemical Biology Doctoral Program, The University of Michigan, Ann Arbor, Michigan, USA.
Abstract:
Studies in microsomal and reconstituted systems have shown that the presence of one cytochrome P450 isoform can significantly influence the catalytic activity of another isoform. In this study, we assessed whether CYP2E1 could influence the catalytic activity of CYP2B4 under steady-state turnover conditions. The results show that CYP2E1 inhibits CYP2B4-mediated metabolism of benzphetamine (BNZ) with a K(i) of 0.04 µM. However, CYP2B4 is not an inhibitor of CYP2E1-mediated p-nitrophenol hydroxylation. When these inhibition studies were performed with the artificial oxidant tert-butyl hydroperoxide, CYP2E1 did not significantly inhibit CYP2B4 activity. Determinations of the apparent K(M) and k(cat) of CYP2B4 for CPR in the presence of increasing concentrations of CYP2E1 revealed a mixed inhibition of CYP2B4 by CYP2E1. At low concentrations of CYP2E1, the apparent K(M) of CYP2B4 for CPR increased up to 23-fold with virtually no change in the k(cat) for the reaction, however, at higher concentrations of CYP2E1, the apparent K(M) of CYP2B4 for CPR decreased to levels similar to those observed in the absence of CYP2E1 and the k(cat) also decreased by 11-fold. Additionally, CYP2E1 increased the apparent K(M) of CYP2B4 for BNZ by 8-fold and the apparent K(M) did not decrease to its original value when saturating concentrations of CPR were used. While the individual apparent K(M) values of CYP2B4 and CYP2E1 for CPR are similar, the apparent K(M) of CYP2E1 for CPR in the presence of CYP2B4 decreased significantly, thus suggesting that CYP2B4 enhances the affinity of CYP2E1 for CPR and this may allow CYP2E1 to out-compete CYP2B4 for CPR.
Insights
Cytochrome P450 2E1 (CYP2E1) inhibits the activity of Cytochrome P450 2B4 (CYP2B4) by affecting its interaction with cytochrome P450 reductase (CPR). This interaction suggests CYP2E1 can outcompete CYP2B4 for CPR.
Area of Science:
- Biochemistry
- Enzymology
- Pharmacology
Background:
- Cytochrome P450 (CYP) isoforms can modulate each other's activity.
- Understanding these interactions is crucial for predicting drug metabolism and toxicity.
Purpose of the Study:
- To investigate the influence of CYP2E1 on the catalytic activity of CYP2B4.
- To elucidate the mechanism of CYP2E1-CYP2B4 interaction.
Main Methods:
- Steady-state enzyme kinetics were used to assess the interaction between CYP2E1 and CYP2B4.
- Benzphetamine (BNZ) and p-nitrophenol were used as substrates.
- The role of cytochrome P450 reductase (CPR) was examined.
Main Results:
- CYP2E1 significantly inhibited CYP2B4-mediated benzphetamine metabolism (Ki = 0.04 µM).
- CYP2E1 exhibited mixed inhibition of CYP2B4 activity concerning CPR, altering both apparent Km and kcat.
- CYP2B4 enhanced CYP2E1's affinity for CPR, suggesting competitive binding.
Conclusions:
- CYP2E1 can inhibit CYP2B4 activity through complex interactions involving CPR.
- CYP2B4 may enhance CYP2E1's affinity for CPR, potentially leading to CYP2E1 outcompeting CYP2B4 for the reductase.
Related Concept Videos
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacokinetics: Drug–Drug Interactions
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug toxicity: Drug–Drug Interaction
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
